10 Nov 2021
Nature Biotechnology publishes LML paper on new medical use patents
‘Mapping the European Patent Landscape for Medical Uses of Known Products’, co-authored by Prof. Mateo Aboy, Prof. Kathy Liddell, Dr John Liddicoat, Dr Cristina Crespo, and Matt Jordan, uses EPO data to examine the European patent landscape of first and further medical uses of known products. Specifically, the paper addresses three research questio…
4 Nov 2021
Stevie Martin awarded Yorke Prize
Dr Stevie Martin has been awarded the Yorke Prize for her doctoral thesis entitled 'Assisted Suicide and the European Convention on Human Rights', which was published by Routledge earlier this year. The Yorke Prize was endowed in 1873 by Edmund Yorke, Scholar and Fellow of St Catharine’s College, and it is awarded annually by the Faculty of Law at …
6 Sep 2021
Tickets still available for CeBIL Symposium 2021 - Orphan Drug Innovation: Needs and Priorities
Tickets are still available to attend the CeBIL Annual Symposium 2021 - Orphan Drug Innovation: Needs and Priorities.Rare diseases affect approximately 25-30 million people in Europe, including millions of children. However, since each disease affects less than one person in every 2,000, the pharmaceutical industry has traditionally been reluctant …
2 Sep 2021
Nature Biotechnology accepts paper from LML on new medical use patents
Nature Biotechnology has accepted a seventh article from LML’s empirical-based IP research group.Most countries active in pharmaceutical innovation offer patent protection and market exclusivity for new medical uses of known products. However, the question of whether such policies offer sustainable business models is an active debate within the fie…
20 Jul 2021
LML published in International Review of Intellectual Property and Competition Law
LML is pleased to announce that International Review of Intellectual Property and Competition Law has published 'Has the EU Incentive for Drug Repositioning Been Effective? An Empirical Analysis of the ‘‘+1’’ Regulatory Exclusivity' by John Liddicoat, Kathy Liddell, Mateo Aboy, and Jakob Wested. This paper forms part of LML's contribution to the Co…
4 Jul 2021
Registration open for Orphan Drug Symposium
LML is delighted to announce that registration has opened for the CeBIL Annual Symposium 2021 - Orphan Drug Innovation: Needs and Priorities.Rare diseases affect approximately 25-30 million people in Europe, including millions of children. However, since each disease affects less than one person in every 2,000, the pharmaceutical industry has tradi…
23 Jun 2021
LML publishes article on cross-border transfers of health data in Journal of Law and the Biosciences
LML is pleased to announce that the Journal of Law and the Biosciences has published ‘Standard contractual clauses for cross-border transfers of health data after Schrems II’, authored by Laura Bradford, Mateo Aboy, and Kathy Liddell.Standard contractual clauses (SCCs) have long been considered the most accessible method to transfer personal data l…
28 Apr 2021
Dr Stevie Martin’s PhD Thesis Published by Routledge
LML is delighted to announce that Dr Stevie Martin’s PhD thesis, ‘Assisted Suicide and the European Convention on Human Rights’, has been published by Routledge.Locating assisted suicide within the broader medical end-of-life context and drawing on the empirical data available from the increasing number of permissive jurisdictions, this book provid…
27 Apr 2021
Dr John Liddicoat participates in Seminar on Drug Repurposing
On 27 April 2021, Dr John Liddicoat (LML Senior Research Associate) participated in ‘Drug Repurposing in the EU – an Innovation Failure’. At this event, part of the Finnish IPR University Center’s Dialogue of Experts series, Dr Liddicoat elaborated on the findings of two forthcoming papers: ‘Has the EU Incentive for Drug Repositioning been Effectiv…
8 Apr 2021
Dr John Liddicoat participates in panel discussion on novelty and repurposing drugs
On 8 April 2021, Dr John Liddicoat (LML Senior Research Associate) participated in a panel discussion on novelty and second medical use patents. Hosted by Life Sciences Intellectual Property Review, ‘Why patent protection is Key to Commercialising Repurposed Drugs’ was a roundtable event which sought to discuss how stakeholders might use patents ma…
26 Mar 2021
Dr John Liddicoat selected as Thomas Edison Fellow
The Thomas Edison Innovation Law and Policy Fellowship is a year-long non-resident programme that brings together leading scholars to develop research on topical issues. The Edison Fellowship is one of the centrepieces of the Centre for the Protection of Intellectual Property's mission to promote a better academic discussion about intellectual prop…
23 Mar 2021
Dr John Liddicoat and James Parish Quoted in UK IPO Review of AI and IP
Last year, the UK Government issued a call for views on artificial intelligence and IP. Dr John Liddicoat (Senior Research Associate) and Mr James Parish (CIPIL) made a short submission addressing AI inventorship. On 23 March 2021, the government published its response to the views it received. The government quoted Dr Liddicoat and Mr Parish on wh…
25 Feb 2021
COVID-19: Ethical frameworks for asymptomatic testing for workplaces and higher education institutions
LML is pleased to announce that two ethical frameworks for the asymptomatic Covid-19 testing in workplaces and higher education institutions, co-authored by LML Director Dr Kathy Liddell, has been published online.Many organisations are considering using asymptomatic Covid-19 testing programmes to reduce risk for individuals on their premises. In O…
22 Feb 2021
Registration Open for Baron de Lancey Lecture 2021 - Law, Hormones, and Sport: a level playing field?
Registration for the 2021 Baron de Lancey Lecture is now open!The 2021 Baron de Lancey Lecture: Law, Hormones, and Sport: A level playing field?How do we ensure a level playing field in sport given natural variations in human biology? When athletes’ biological levels differ from the norm set by their federation for a given sport, what is to be done…
25 Jan 2021
Save the Date - Baron de Lancey Lecture 2021: Law, Hormones, and Sport: a level playing field?
Update:Registration is now open! Please click here to register your attendance.The 2021 Baron de Lancey Lecture: Law, Hormones, and Sport: A level playing field?How do we ensure a level playing field in sport given natural variations in human biology? When athletes’ biological levels differ from the norm set by their federation for a given sport, w…
